{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T23:28:51Z","timestamp":1768346931374,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":1135,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1136\/ijgc-2021-002978","type":"journal-article","created":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T13:30:13Z","timestamp":1635255013000},"page":"ijgc-2021-002978","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Ascites volume at the time of primary debulking and overall survival of patients with advanced epithelial ovarian cancer"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6260-5353","authenticated-orcid":false,"given":"Dimitrios","family":"Nasioudis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily M","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley F","family":"Haggerty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lori","family":"Cory","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert L","family":"Giuntoli II","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah H","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nawar A","family":"Latif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2021-002978_bb0010","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/jnci\/djy071","article-title":"Invasive epithelial ovarian cancer survival by histotype and disease stage","volume":"111","author":"Peres","year":"2019","journal-title":"J Natl Cancer Inst"},{"key":"10.1136\/ijgc-2021-002978_bb0015","doi-asserted-by":"crossref","first-page":"v23","DOI":"10.1093\/annonc\/mdq244","article-title":"Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"21(Suppl 5)","author":"Colombo","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1136\/ijgc-2021-002978_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00595","article-title":"Ascites volumes and the ovarian cancer microenvironment","volume":"8","author":"Penet","year":"2018","journal-title":"Front Oncol"},{"key":"10.1136\/ijgc-2021-002978_bb0025","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1136\/ijgc-2019-000310","article-title":"Correlation of differential ascites volume with primary cytoreductive surgery outcome, lymph node involvement, and disease recurrence in advanced ovarian cancer","author":"Lai","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2021-002978_bb0030","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ygyno.2015.04.013","article-title":"Development of a prediction model for residual disease in newly diagnosed advanced ovarian cancer","volume":"138","author":"Janco","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002978_bb0035","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ygyno.2017.11.018","article-title":"Clinicopathologic characteristics associated with long-term survival in advanced epithelial ovarian cancer: an NRG Oncology\/Gynecologic Oncology Group ancillary data study","volume":"148","author":"Hamilton","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002978_bb0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ygyno.2015.07.103","article-title":"Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: an NRG Oncology\/GOG study","volume":"139","author":"Ferriss","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002978_bb0045","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ygyno.2017.06.008","article-title":"Impact of ascites volume on clinical outcomes in ovarian cancer: a cohort study","volume":"146","author":"Szender","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002978_bb0050","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1111\/jog.14682","article-title":"Relationship between ascites volume and clinical outcomes in epithelial ovarian cancer","volume":"47","author":"Quan","year":"2021","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1136\/ijgc-2021-002978_bb0055","doi-asserted-by":"crossref","first-page":"546","DOI":"10.4149\/neo_2013_071","article-title":"Clinical significance of ascites in epithelial ovarian cancer","volume":"60","author":"Huang","year":"2013","journal-title":"Neoplasma"},{"key":"10.1136\/ijgc-2021-002978_bb0060","doi-asserted-by":"crossref","DOI":"10.1186\/s13048-016-0294-z","article-title":"Ascites regression following neoadjuvant chemotherapy in prediction of treatment outcome among stage IIIC to IV high-grade serous ovarian cancer","volume":"9","author":"Xu","year":"2016","journal-title":"J Ovarian Res"},{"key":"10.1136\/ijgc-2021-002978_bb0065","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41416-020-0875-x","article-title":"The untapped potential of ascites in ovarian cancer research and treatment","volume":"123","author":"Ford","year":"2020","journal-title":"Br J Cancer"},{"key":"10.1136\/ijgc-2021-002978_bb0070","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ygyno.2012.05.002","article-title":"VEGF induces ascites in ovarian cancer patients via increasing peritoneal permeability by downregulation of claudin 5","volume":"127","author":"Herr","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002978_bb0075","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ygyno.2007.09.020","article-title":"Nomogram for survival after primary surgery for bulky stage IIIC ovarian carcinoma","volume":"108","author":"Chi","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002978_bb0080","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/IGC.0000000000000069","article-title":"Impact of ascites on the perioperative course of patients with advanced ovarian cancer undergoing extensive cytoreduction: results of a study on 119 patients","volume":"24","author":"Feldheiser","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2021-002978_bb0085","doi-asserted-by":"crossref","first-page":"64","DOI":"10.5468\/ogs.2020.63.1.64","article-title":"Factors associated with surgical morbidity of primary debulking in epithelial ovarian cancer","volume":"63","author":"G\u00fcnakan","year":"2020","journal-title":"Obstet Gynecol Sci"},{"key":"10.1136\/ijgc-2021-002978_bb0090","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s00404-011-1864-3","article-title":"Usefulness of computed tomography in predicting cytoreductive surgical outcomes for ovarian cancer","volume":"284","author":"Fujwara","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"10.1136\/ijgc-2021-002978_bb0095","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ygyno.2017.02.020","article-title":"A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer","volume":"145","author":"Suidan","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002978_bb0100","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/sj.bjc.6605292","article-title":"Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial","volume":"101","author":"Ferrandina","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1136\/ijgc-2021-002978_bb0105","doi-asserted-by":"crossref","first-page":"546","DOI":"10.4149\/neo_2013_071","article-title":"Clinical significance of ascites in epithelial ovarian cancer","volume":"60","author":"Huang","year":"2013","journal-title":"Neoplasma"},{"key":"10.1136\/ijgc-2021-002978_bb0110","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrc2714","article-title":"Environment-mediated drug resistance: a major contributor to minimal residual disease","volume":"9","author":"Meads","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1136\/ijgc-2021-002978_bb0115","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ygyno.2015.05.009","article-title":"Cytokine profiling of ascites at primary surgery identifies an interaction of tumor necrosis factor-\u03b1 and interleukin-6 in predicting reduced progression-free survival in epithelial ovarian cancer","volume":"138","author":"Kolomeyevskaya","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002978_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00595","article-title":"Ascites volumes and the ovarian cancer microenvironment","volume":"8","author":"Penet","year":"2018","journal-title":"Front Oncol"},{"key":"10.1136\/ijgc-2021-002978_bb0125","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1158\/2326-6066.CIR-15-0086","article-title":"Extracellular vesicles present in human ovarian tumor microenvironments induce a phosphatidylserine-dependent arrest in the T-cell signaling cascade","volume":"3","author":"Kelleher","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"10.1136\/ijgc-2021-002978_bb0130","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1200\/JCO.19.01009","article-title":"Final overall survival of a randomized trial of bevacizumab for primary treatment of ovarian cancer","volume":"37","author":"Tewari","year":"2019","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X25001021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X25001021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2021-002978","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:28:34Z","timestamp":1753234114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X25001021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1048891X25001021"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2021-002978","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ascites volume at the time of primary debulking and overall survival of patients with advanced epithelial ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2021-002978","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}],"article-number":"ijgc-2021-002978"}}